Who
Jonathan Sheena
Director and Other role
Company insider
Files Form 4 as: Co-Founder, Natera.
In numbers
- Trades disclosed
- 970
- Buys
- 0
- Sells
- 183
- Bought
- $0
- Sold
- $134.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Dec 2015
- Last trade
- 21 Oct 2026
- Last filed
- 23 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Oct 2026filed 23 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $81K200 at $406.50 | filing |
| 21 Oct 2026filed 23 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $393K962 at $408.26 | filing |
| 21 Oct 2026filed 23 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $257K627 at $409.89 | filing |
| 21 Oct 2026filed 23 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $249K605 at $411.32 | filing |
| 21 Oct 2026filed 23 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $87K211 at $412.20 | filing |
| 21 Oct 2026filed 23 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $52K125 at $413.05 | filing |
| 21 Oct 2026filed 23 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $106K255 at $415.67 | filing |
| 21 Oct 2026filed 23 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $69K165 at $416.67 | filing |
| 16 Oct 2026filed 20 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $86K215 at $399.34 | filing |
| 16 Oct 2026filed 20 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $36K90 at $403.70 | filing |
| 16 Oct 2026filed 20 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $32K80 at $406.06 | filing |
| 16 Oct 2026filed 20 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $40K98 at $409.34 | filing |
| 16 Oct 2026filed 20 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $112K280 at $401.29 | filing |
| 16 Oct 2026filed 20 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $36K90 at $404.25 | filing |
| 16 Oct 2026filed 20 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $20K50 at $405.15 | filing |
| 16 Oct 2026filed 20 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $14K35 at $406.63 | filing |
| 16 Oct 2026filed 20 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $33K80 at $409.36 | filing |
| 16 Oct 2026filed 20 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $57K142 at $398.95 | filing |
| 16 Oct 2026filed 20 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $112K280 at $400.68 | filing |
| 16 Oct 2026filed 20 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $24K60 at $401.62 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Financial Comparison: Valneva (NASDAQ:VALN) and Natera (NASDAQ:NTRA)NTRA · tickerreport.com · 22 Oct 2026Natera (NTRA) Is Expanding Cancer Testing Rapidly. Does Its Valuation Leave Room for Error?NTRA · insidermonkey.com · 20 Oct 2026ESMO 2026 Presentations Deepen the Evidence Base for Natera's Oncology Portfolio and Leadership in Ultrasensitive MRD Technology | wallstreetONLINENTRA · wallstreet-online.de · 19 Oct 2026
0 headlines in the last 90 days name Jonathan Sheena; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.